AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. OGEN
  4. [EFFECT] Oragenics Inc. SEC Filing

[EFFECT] Oragenics Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 30, 2025 4:30 P.M.
Form: S-1
CIK: 0001174940
Company Name: ORAGENICS INC
File Number: 333-288225

Source:

Stock OGEN logo
Oragenics

NYSE:OGEN

OGEN Rankings

#11806 Ranked by Market Cap
N/A Ranked by Dividends

OGEN Latest News

Aug 11, 2025
Oragenics Q2 2025 Shareholder Update
Jul 31, 2025
Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial
Jul 16, 2025
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development
Jul 2, 2025
Oragenics Completes Approximately $16.5 Million Offering
Jul 1, 2025
Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants

OGEN Latest SEC Filings

Aug 11, 2025
[8-K] Oragenics Inc. Reports Material Event
Aug 8, 2025
[10-Q] Oragenics Inc. Quarterly Earnings Report
Jul 2, 2025
[8-K] Oragenics Inc. Reports Material Event
Jul 2, 2025
[SCHEDULE 13G] Oragenics Inc. SEC Filing
Jul 2, 2025
[424B5] Oragenics Inc. Prospectus Supplement (Debt Securities)

OGEN Stock Data

1.08M
723.29k
12.11%
1.26%
8.27%
Biotechnology
Pharmaceutical Preparations
United States
SARASOTA